title: Navelbine in advanced ovarian epithelial cancer: a study of the French oncology centers.
authors.affiliation: Institut Gustave Roussy, Villejuif, France.
authors.forename: M J
authors.initials: MJ
authors.lastname: George
authors.forename: J F
authors.initials: JF
authors.lastname: Heron
authors.forename: P
authors.initials: P
authors.lastname: Kerbrat
authors.forename: J
authors.initials: J
authors.lastname: Chauvergne
authors.forename: A
authors.initials: A
authors.lastname: Goupil
authors.forename: D
authors.initials: D
authors.lastname: Lebrun
authors.forename: J P
authors.initials: JP
authors.lastname: Guastalla
authors.forename: M
authors.initials: M
authors.lastname: Namer
authors.forename: R
authors.initials: R
authors.lastname: Bugat
authors.forename: Y
authors.initials: Y
authors.lastname: Ayme
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy*; D003131:Combined Modality Therapy; D003248:Constipation / Q000139:chemically induced; D004341:Drug Evaluation; D005260:Female; D005602:France; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009325:Nausea / Q000139:chemically induced; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D012074:Remission Induction; D014747:Vinblastine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077235:Vinorelbine; D014839:Vomiting / Q000139:chemically induced
chemical_list: D000970:Antineoplastic Agents; D014747:Vinblastine; D000077235:Vinorelbine